A detailed history of Federated Hermes, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 167 shares of OMER stock, worth $1,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Holding current value
$1,439
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.54 - $5.47 $591 - $913
167 New
167 $0
Q2 2023

Aug 14, 2023

BUY
$4.45 - $7.57 $404 - $688
91 New
91 $0
Q3 2021

Nov 15, 2021

SELL
$13.4 - $16.3 $365,243 - $444,289
-27,257 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$14.81 - $19.13 $3.99 Million - $5.16 Million
-269,513 Reduced 90.82%
27,257 $404,000
Q1 2021

May 13, 2021

BUY
$14.52 - $23.53 $4.31 Million - $6.98 Million
296,629 Added 210375.19%
296,770 $5.28 Million
Q3 2018

Nov 13, 2018

BUY
$17.73 - $26.69 $2,499 - $3,763
141 New
141 $3,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $541M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.